簡要描述:Atlas Antibodies 抗體試劑銷售銷售銷售Atlas開發(fā)與人類蛋白有關(guān)的抗體以及試劑,基于質(zhì)譜(MS)的定量蛋白質(zhì)組學(xué),在人體中可能的20,000種蛋白質(zhì)編碼基因中,Atlas已經(jīng)具有覆蓋15,000種的基因產(chǎn)物,超過17,000種抗體,約13,000種蛋白質(zhì)靶標(biāo)。
詳細(xì)介紹
品牌 | 其他品牌 | 供貨周期 | 現(xiàn)貨 |
---|---|---|---|
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,食品,化工,生物產(chǎn)業(yè),制藥 |
Atlas Antibodies 抗體試劑銷售銷售銷售
Atlas Antibodies 抗體試劑銷售銷售銷售
上海易匯生物科技有限公司擁有強大的采購系統(tǒng)。只要您想得到。沒有公司采購辦不到的。
上海易匯生物科技有限公司擁有完善的售后平臺。只要有售后。我們*時間為您解決。
上海易匯生物科技有限公司直接與廠家合作。保證貨源正品。購買無后顧之憂。
上海易匯生物科技有限公司不保證100%。但保證100%產(chǎn)品都是正品。
我們長期與Thermo Bio-rad Axygen qiagen Corning BD Promega Biotium BV targetmol merckmillipore Sigma AAT-Biolite biorbyt ENZO GE Greiner Immonoway Jackson leagene nunc Omega OmnimAbs PMG RD ZOMANBIO 聚仕隆serum 普羅麥格 金鐘 Eaivelly阿拉丁,麥克林,TCI LKT Laboratories,Epigentek,Biovision,Abnova Oxoid等各*保持合作。
張經(jīng)理:Q821536999
上海易匯生物科技有限公司銷售銷售
Atlas Antibodies
Atlas開發(fā)與人類蛋白有關(guān)的抗體以及試劑,基于質(zhì)譜(MS)的定量蛋白質(zhì)組學(xué),在人體中可能的20,000種蛋白質(zhì)編碼基因中,Atlas已經(jīng)具有覆蓋15,000種的基因產(chǎn)物,超過17,000種抗體,約13,000種蛋白質(zhì)靶標(biāo)。
At Atlas Antibodies we have a very clear mission: To provide our customers with advanced research reagents targeting all human proteins.
TheHuman Protein Atlas (HPA) project released the first version of a complete tissue-based map of human protein expression using antibodies in November 2014. In close partner ship with the HPA project, we continue to develop advanced antibodies and advanced reagents for Mass Spectrometry (MS)-based quantitative proteomics.
Of the possible 20,000 protein coding genes in the human body we already have over 18,000 antibodies covering 15,000 gene products and an additional 19,000 protein quantification MS-standards representing 13,000 protein targets. Learn more in this short film about us.
Atlas Antibodies has a very special story. The company was founded by researchers from the prestigious Human Protein Atlas project, who wanted to make the unique antibodies used in the project available to fellow researchers worldwide.
The Human Protein Atlas was initiated in 2003 by Swedish researchers, headed by Professor Mathias Uhlén, and is funded by the Knut and Alice Wallenberg foundation. It is a unique world leading effort to create a complete immunohistochemistry based map of human protein expression and localization in normal tissues, cancers and cell lines.
The project launched a first version of the complete human proteome on November 6, 2014, and plans to present a curated version finished by 2020.
產(chǎn)品列表:
供貨商 | 產(chǎn)品編號 | 產(chǎn)品名稱 | 規(guī)格 |
Atlas antibodies | AMAb90501 | Anti-SOX11 | 100 µl |
Atlas antibodies | AMAb90502 | Anti-SOX11 | 100 µl |
Atlas antibodies | AMAb90510 | Anti-ZEB1 | 100 µl |
Atlas antibodies | AMAb90516 | Anti-VIM | 100 µl |
Atlas antibodies | AMAb90518 | Anti-CD45 | 100 µl |
Atlas antibodies | AMAb90519 | Anti-CD45 | 100 µl |
Atlas antibodies | AMAb90523 | Anti-TG | 100 µl |
Atlas antibodies | AMAb90525 | Anti-CHGA | 100 µl |
Atlas antibodies | AMAb90529 | Anti-APOL1 | 100 µl |
Atlas antibodies | AMAb90530 | Anti-APOL1 | 100 µl |
Atlas antibodies | AMAb90532 | Anti-APOL1 | 100 µl |
Atlas antibodies | AMAb90535 | Anti-ADAR | 100 µl |
Atlas antibodies | AMAb90537 | Anti-AQP4 | 100 µl |
Atlas antibodies | AMAb90541 | Anti-ATAD2 | 100 µl |
Atlas antibodies | AMAb90544 | Anti-SIX1 | 100 µl |
Atlas antibodies | AMAb90545 | Anti-ARG1 | 100 µl |
Atlas antibodies | AMAb90549 | Anti-FUS | 100 µl |
Atlas antibodies | AMAb90556 | Anti-NES | 100 µl |
Atlas antibodies | AMAb90558 | Anti-ANXA1 | 100 µl |
Atlas antibodies | AMAb90560 | Anti-EMD | 100 µl |
Atlas antibodies | AMAb90562 | Anti-EMD | 100 µl |
Atlas antibodies | AMAb90565 | Anti-PCM1 | 100 µl |
Atlas antibodies | AMAb90569 | Anti-NLRP3 | 100 µl |
Atlas antibodies | AMAb90572 | Anti-SLC27A5 | 100 µl |
Atlas antibodies | AMAb90574 | Anti-SLC27A5 | 100 µl |
Atlas antibodies | AMAb90575 | Anti-SLC27A5 | 100 µl |
Atlas antibodies | AMAb90578 | Anti-IDH1 | 100 µl |
Atlas antibodies | AMAb90582 | Anti-RNASE7 | 100 µl |
Atlas antibodies | AMAb90583 | Anti-RNASE7 | 100 µl |
Atlas antibodies | AMAb90584 | Anti-FBN1 | 100 µl |
Atlas antibodies | AMAb90585 | Anti-FBN1 | 100 µl |
Atlas antibodies | AMAb90591 | Anti-RUNX2 | 100 µl |
Atlas antibodies | AMAb90594 | Anti-RUNX2 | 100 µl |
Atlas antibodies | AMAb90595 | Anti-FABP7 | 100 µl |
Atlas antibodies | AMAb90596 | Anti-S100A4 | 100 µl |
Atlas antibodies | AMAb90598 | Anti-S100A4 | 100 µl |
Atlas antibodies | AMAb90599 | Anti-S100A4 | 100 µl |
Atlas antibodies | AMAb90600 | Anti-VANGL1 | 100 µl |
Atlas antibodies | AMAb90616 | Anti-STX7 | 100 µl |
Atlas antibodies | AMAb90621 | Anti-TSPAN7 | 100 µl |
Atlas antibodies | AMAb90624 | Anti-TSPAN7 | 100 µl |
Atlas antibodies | AMAb90627 | Anti-HER2 | 100 µl |
Atlas antibodies | AMAb90628 | Anti-HER2 | 100 µl |
Atlas antibodies | AMAb90630 | Anti-SCGN | 100 µl |
Atlas antibodies | AMAb90632 | Anti-SCGN | 100 µl |
產(chǎn)品咨詢